This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.
The purpose of this acquisition is to acquire and deliver Cidofovir 375mg/5ml injection single dose vials to the DSNS.
For further information, please see the attachment.
Caleb Owen, Contract Specialist, Phone 2024015253, Email caleb.owen@hhs.gov - Heather Orandi, Contract Specialist, Phone 202-205-5818, Email heather.orandi@hhs.gov